323 related articles for article (PubMed ID: 15817068)
1. Clinical significance of total and lipid bound sialic acid levels in oral pre-cancerous conditions and oral cancer.
Rajpura KB; Patel PS; Chawda JG; Shah RM
J Oral Pathol Med; 2005 May; 34(5):263-7. PubMed ID: 15817068
[TBL] [Abstract][Full Text] [Related]
2. Correlation of serum biomarkers (TSA & LSA) and epithelial dysplasia in early diagnosis of oral precancer and oral cancer.
Sawhney H; Kumar CA
Cancer Biomark; 2011-2012; 10(1):43-9. PubMed ID: 22297551
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of serum sialic acid, sialyltransferase and sialoproteins in oral cavity cancer.
Raval GN; Patel DD; Parekh LJ; Patel JB; Shah MH; Patel PS
Oral Dis; 2003 May; 9(3):119-28. PubMed ID: 12945593
[TBL] [Abstract][Full Text] [Related]
4. Alterations in plasma lipid profile patterns in head and neck cancer and oral precancerous conditions.
Patel PS; Shah MH; Jha FP; Raval GN; Rawal RM; Patel MM; Patel JB; Patel DD
Indian J Cancer; 2004; 41(1):25-31. PubMed ID: 15105576
[TBL] [Abstract][Full Text] [Related]
5. Significance of serum sialoglycoproteins in patients with lung cancer.
Patel PS; Baxi BR; Balar DB
Neoplasma; 1989; 36(1):53-9. PubMed ID: 2539569
[TBL] [Abstract][Full Text] [Related]
6. Lipid peroxidation, total antioxidant status, and total thiol levels predict overall survival in patients with oral squamous cell carcinoma.
Patel BP; Rawal UM; Dave TK; Rawal RM; Shukla SN; Shah PM; Patel PS
Integr Cancer Ther; 2007 Dec; 6(4):365-72. PubMed ID: 18048884
[TBL] [Abstract][Full Text] [Related]
7. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of patients with premalignant and malignant lesions of the oral cavity.
Rajendran R; Remani P; Vijayakumar T; Vasudevan DM
Ann Dent; 1990; 49(1):36-8, 51. PubMed ID: 2346298
[TBL] [Abstract][Full Text] [Related]
8. Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker.
Shah M; Telang S; Raval G; Shah P; Patel PS
Cancer; 2008 Jul; 113(2):336-46. PubMed ID: 18521898
[TBL] [Abstract][Full Text] [Related]
9. Can quantifying free-circulating DNA be a diagnostic and prognostic marker in oral epithelial dysplasia and oral squamous cell carcinoma?
Shukla D; Kale AD; Hallikerimath S; Yerramalla V; Subbiah V
J Oral Maxillofac Surg; 2013 Feb; 71(2):414-8. PubMed ID: 22749518
[TBL] [Abstract][Full Text] [Related]
10. Serum sialic acid, fucose, sialic acid/fucose ratio as tumor markers in oral cancer.
Ghosh M; Nayak BR
Ann Dent; 1991; 50(2):33-5, 48. PubMed ID: 1785913
[TBL] [Abstract][Full Text] [Related]
11. Importance of serum sialic acid and lactate dehydrogenase in diagnosis and treatment monitoring of cervical cancer patients.
Patel PS; Rawal GN; Balar DB
Gynecol Oncol; 1993 Sep; 50(3):294-9. PubMed ID: 8406190
[TBL] [Abstract][Full Text] [Related]
12. Total and lipid-bound plasma sialic acid as diagnostic markers in colorectal cancer patients: correlation with cathepsin B expression in progression to Dukes stage.
Sebzda T; Saleh Y; Gburek J; Warwas M; Andrzejak R; Siewinski M; Rudnicki J
J Exp Ther Oncol; 2006; 5(3):223-9. PubMed ID: 16528972
[TBL] [Abstract][Full Text] [Related]
13. Estimation and comparative study of serum total sialic acid levels as tumor markers in oral cancer and precancer.
Joshi M; Patil R
J Cancer Res Ther; 2010; 6(3):263-6. PubMed ID: 21119250
[TBL] [Abstract][Full Text] [Related]
14. Study of serum fucose and serum sialic acid levels in oral squamous cell carcinomia.
Shashikanth MC; Rao BB
Indian J Dent Res; 1994; 5(4):119-24. PubMed ID: 9495093
[TBL] [Abstract][Full Text] [Related]
15. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital.
Hsue SS; Wang WC; Chen CH; Lin CC; Chen YK; Lin LM
J Oral Pathol Med; 2007 Jan; 36(1):25-9. PubMed ID: 17181738
[TBL] [Abstract][Full Text] [Related]
16. Serum soluble CD44v6 levels in patients with oral and maxillofacial malignancy.
Chang SM; Xing RD; Zhang FM; Duan YQ
Oral Dis; 2009 Nov; 15(8):570-2. PubMed ID: 19563418
[TBL] [Abstract][Full Text] [Related]
17. Serum copper and zinc levels in premalignant and malignant lesions of the oral cavity.
Varghese I; Sugathan CK; Balasubramoniyan G; Vijayakumar T
Oncology; 1987; 44(4):224-7. PubMed ID: 3614812
[TBL] [Abstract][Full Text] [Related]
18. Glutathione, ascorbic acid and antioxidant enzymes in the tumor tissue and blood of patients with oral squamous cell carcinoma.
Fiaschi AI; Cozzolino A; Ruggiero G; Giorgi G
Eur Rev Med Pharmacol Sci; 2005; 9(6):361-7. PubMed ID: 16479741
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of serum glycoconjugates in precancerous and cancerous diseases of the oral cavity.
Baxi BR; Patel PS; Adhvaryu SG; Dayal PK
Cancer; 1991 Jan; 67(1):135-40. PubMed ID: 1985709
[TBL] [Abstract][Full Text] [Related]
20. A case control study of glycoprotein status in ovarian carcinoma.
Aranganathan S; Senthil K; Nalini N
Clin Biochem; 2005 Jun; 38(6):535-9. PubMed ID: 15885233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
